Frontiers in Cardiovascular Medicine (May 2022)

Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction

  • Oriol Iborra-Egea,
  • Oriol Iborra-Egea,
  • Alberto Aimo,
  • Alberto Aimo,
  • Antoni Bayes-Genis,
  • Antoni Bayes-Genis,
  • Antoni Bayes-Genis

DOI
https://doi.org/10.3389/fcvm.2022.887236
Journal volume & issue
Vol. 9

Abstract

Read online

No abstracts available.

Keywords